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We have isolated and sequenced two cDNAs of sizes 2674 and 677 bp from a cDNA library derived from MKT-1, a
lymphoblastoid cell line transformed and latently infected with Marek’s disease virus (MDV) using probes corresponding to
the right-hand end of the BamHI-I2 fragment of the MDV genome. The larger cDNA clone represents an abundant transcript,
which extends from the right-hand end of BamHI-I2 to the adjacent BamHI-Q2 and BamHI-L fragments of the MDV genome
and contains the Meq (MDV Eco-Q) open reading frame. The smaller cDNA clone represents a spliced transcript containing
the putative DNA binding domain of Meq as well as sequences in the BamHI-L region. We prepared a polyclonal antibody
against part of the protein sequence of Meq and detected a 44-kDa protein in MKT-1 cells and in cells lytically infected
with MDV. In addition, riboprobes corresponding to sequences specific to each cDNA as well as shared sequences between
cDNAs detected a number of transcripts in cells either lytically or latently infected with MDV. Our results indicate that the
Meq transcriptional unit extends to the BamHI-L fragment and that the transcripts mapping to the right-hand end of the
BamHI-I2 and adjacent BamHI-Q2 and BamHI-L fragments are not preferentially expressed during latency. q 1995 Academic
Press, Inc.
INTRODUCTION and transformed cells, such as those derived from MDV-
induced tumors in chicken and established lymphoblas-
Marek’s disease virus (MDV) is an avian herpesvirus toid cells, is restricted to the terminal and internal repeat
which is classified as an alphaherpesvirus on the basis regions (Silver et al., 1979a,b; Sugaya et al., 1990). These
of its genomic structure (Buckmaster et al., 1988; Fukuchi observations suggest that the transcripts within these
et al., 1984). In its natural host, the chicken, MDV induces regions may be important in MDV-induced latency and/
a lymphoproliferative disease at multiple sites, and with or tumorigenicity. Serial in vitro passage of an oncogenic
some strains a demyelinative peripheral neuropathy has MDV strain in primary chicken fibroblasts (CEF) led to a
been reported (Calnek, 1980, 1992; Payne, 1982). The loss of MDV tumorigenicity, which correlated with ampli-
pathogenesis of MDV is characterized by a cytolytic in- fication of a 132-bp direct repeat present in MDV TRL and
fection of B cells in spleen, thymus, and bursa of Fab- IRL (BamHI-D and BamHI-H DNA fragments, respectively)
ricius followed by a latent infection of splenic and primary (Fukuchi et al., 1985; Silva and Witter, 1985; Maotani et
blood lymphocytes and concomitant transformation of al., 1986). Amplification of the 132-bp repeat was corre-
the latently infected cells. Tumor induction by MDV can lated with the truncation of a family of transcripts, the
be prevented by vaccination of chickens with attenuated BamHI-H gene family, in nononcogenic MDV strains
MDV (Churchill et al., 1969) or with the antigenically re- (Bradley et al., 1989; Peng et al., 1992). Other transcripts
lated herpesvirus of turkey, HVT (Okazaki et al., 1970); that are initiated near the 132-bp repeat have also been
however, the mechanism of oncogenesis by MDV re- described. For example, a transcript encoding a 38-kDa
quires further investigation. phosphoprotein, which is highly expressed in cells lyti-
The MDV genome consists of long (L) and short (S) cally infected with MDV as well as in tumor cells trans-
unique sequences, each flanked by terminal (TRL and formed and latently infected with MDV, was shown to be
TRS) and internal (IRL and IRS) inverted repeats (Fukuchi transcribed in a leftward direction (Cui et al., 1991; Chen
et al., 1984). MDV gene transcription in latently infected et al., 1992).
The IRL also contains BamHI-I2 , BamHI-Q2 , and
BamHI-L fragments. Previously, it was demonstrated that1 To whom correspondence and reprint requests should be ad-
a number of latent transcripts clustering in the short anddressed at Laboratory of Tumor Virology, Tampa Bay Research Institute,
10900 Roosevelt Blvd., St. Petersburg, FL 33716. Fax: (813) 577-9862. long repeat regions were detected in MKT-1, a MDV-
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transformed nonproductive lymphoblastoid cell line, as kuchi et al., 1984) and cloned into the polylinker region
of the Bluescript M13 vector (Strategene, La Jolla, CA).well as in kidney lymphoma cells obtained from MDV-
infected chickens (Tanaka et al., 1978; Sugaya et al., Probes I and II (Fig. 1) were amplified by PCR (see below)
from the 677- and 2674-bp cDNAs, respectively, and1990). The most abundant transcripts were mapped to
the right-hand end of the BamHI-I2 fragment (Sugaya et cloned into EcoRI and HindIII sites of the pGEM 11zf(/)
(Promega, Madison, WI). Antisense riboprobes were pre-al., 1990). In addition, studies by Jones et al. (1992) dem-
onstrated that the Eco-Q fragment of the MDV genome, pared by in vitro transcription using T3, T7, or SP6 poly-
merases in accordance with the manufacturer’s instruc-which encompasses the right-hand end of the BamHI-
I2 and adjacent BamHI-Q2 fragment, contained an open tions (Promega) and labeled with [a-
32P]CTP (800 Ci/
mmol, New England Nuclear, Boston, MA).reading frame (ORF) referred to as Meq (MDV Eco-Q
protein). This ORF was shown to encode a 40-kDa protein
Extraction of RNA and Northern blot hybridizationwith homology to the transcriptional activators c-jun and
c-fos and was demonstrated to function as a tran- Total RNA was isolated by the method of Chomczynski
scriptional transactivator (Curran and Franza, 1988; and Sacchi (1987), and the poly(A)/ fraction was obtained
Landschulz et al., 1988; Mitchell and Tjian, 1989; Johnson using a poly(A)/ isolation kit which employed the strep-
and McKnight, 1989; Jones et al., 1992; Qian et al., 1995). tavidin–biotin–magnetic bead technique (Promega).
Jones et al. (1992) isolated several cDNA clones corre- Poly(A)/ RNA (1–2 mg) was electrophoresed through a
sponding to transcripts originating from the Eco-Q frag- 0.8% agarose gel containing 7.2% formaldehyde, trans-
ment from various MDV-transformed tumor cell lines and ferred onto nitrocellulose, and hybridized with the appro-
showed that these transcripts were initiated from a TATA- priate probe. An RNA ladder from 0.24 to 9.5 kb was used
containing promoter element located in the right-hand as a size marker (Gibco–BRL).
end of the BamHI-I2 . However, recent cDNA cloning stud- Northern blot hybridizations were performed overnight
ies by Ohashi et al. (1994) suggested that the Meq tran- at 657 in 51 SSC (0.75 M NaCl, 75 mM sodium citrate),
scriptional unit may extend to the BamHI-L fragment. 11 PE [50 mM Tris–HCl, pH 7.5, 0.1% (w/v) sodium pyro-
In an attempt to analyze in more detail the transcrip- phosphate, 1% SDS, 0.2% polyvinylpyrrolidone (MW
tional activity of the right-hand end of the BamHI-I2 frag- 40,000), 0.2% Ficoll (MW 400,000), 5 mM EDTA, 0.2% bo-
ment, we constructed a cDNA library from MKT-1 cells vine serum albumin], 50% deionized formamide, and 150
and isolated two cDNAs corresponding to the right-hand mg/ml denatured salmon sperm DNA. Blots were then
end of the BamHI-I2 and adjacent BamHI-Q2 and BamHI- washed twice at 657 in 21 SSC, 0.1% SDS for 15 min
L fragments. We present the sequence of these MDV each and twice in 0.1% SSC, 0.1% SDS for 15 min each.
cDNAs and the results of Northern blot analyses with
strand-specific riboprobes in both lytically and latently DNA sequencing and computer-assisted sequence
infected cells. analyses
Sanger’s dideoxy chain termination method using the
MATERIALS AND METHODS Sequenase Version 2.0 kit (United States Biochemical
Corp., Cleveland, OH) and the Autoread T7 polymeraseCells and viruses
kit in combination with the ALF automatic DNA se-
The lymphoblastoid cell line MKT-1 was established quencer (Pharmacia, Piscataway, NJ) were used for DNA
from Marek’s disease tumors in chickens injected with sequencing of both strands (Sanger et al., 1977). Com-
the GA strain of MDV and was shown to be nonproduc- puter analysis of the DNA sequence was performed us-
tive of viral antigens (Tanaka et al., 1978). The CVI988 ing the Intelligenetics Suite Release 5.4 and the PC/
strain of MDV (Rispens et al., 1972) was used for infection GENE software Release 6.8 (Intelligenetics, Inc., Moun-
of primary CEF, as described previously (Fukuchi et al., tain View, CA).
1984). UT-1, a reticuloendotheliosis virus-infected T lym-
phocyte cell line was kindly provided by Dr. Lucy Lee, Primers and PCR amplification
USDA/ARS, East Lansing, Michigan. MKT-1 and UT-1
The primer sets 5*-CCACATTGCTCCGGTTCCCAA-3*cells were maintained in RPMI 1640 (Gibco–BRL, Grand
and 5*-ATAGACGATGTGCTGCTGAG-3* (Fig. 2A, primers 1Island, NY) containing 5 and 20% newborn calf serum
and 2, respectively) and 5*-ATGTCTCAGGAGCCAGAG-3*(Intergen, Purchase, NY), respectively.
and 5*-TATTATATATAACTAGGGG-3* (Fig. 2A, primers 3
and 4, respectively) were used to confirm the presence ofProbes
the repeat region in the 2674-bp cDNA. The primer set 5*-
GGTCGACTTCGAGACGGAAAA-3* and 5*-TCGCGGATC-The ClaI– Sal I and Sal I–BamHI subfragments of
BamHI-I2 (Fig. 1, probes III and IV, respectively) were CTAAAGCAGTCCAAGGGTCAC-3* (Fig. 2A, primers 5 and
6, respectively) was used to amplify the DNA fragmentobtained according to the previously determined restric-
tion enzyme sites on the BamHI-I2 DNA fragment (Fu- encoding the most antigenic protein sequence of Meq (see
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FIG. 1. A schematic representation of the MDV gene organization and location of cDNAs mapping to BamHI-I2 , BamHI-Q2 , and BamHI-L fragments.
UL , unique long sequence; US , unique short sequence; IRL , long inverted repeat; IRS , short inverted repeat; TRL , long terminal repeat; TRS , short
terminal repeat. Solid bars indicate the location of probes I, II, III, and IV used in Northern blot hybridization. Probes III and IV were also used for
cDNA library screening. The locations of 2674- and 677-bp cDNAs isolated from MKT-1 cDNA library are shown. B, Ss, C, X, and Sa refer to BamHI,
SstII, ClaI, XbaI, and Sal I restriction sites, respectively. The hatched boxes indicate the shared sequences between the two cDNAs.
below). The primers 5*-CTTCTCCCCTAGTTATAT-3* (Fig. the SmaI–BamHI site of the pGEX-4T-3 vector (Pharmacia)
as a fusion protein in frame with the glutathione S-trans-2A, primer 7) and 5*-GAGAATTCAAACTATTCTTG-3* (Fig.
2A, primer 8) corresponding to nt 1276 to 1294 and nt 2318 ferase (GST) gene, driven by a isopropyl-b-D-thiogalactopy-
ranoside (IPTG)-inducible tac promoter. The authenticity ofto 2289 of the 2674-bp cDNA, respectively, were used to
amplify a 1042-bp product from this cDNA (Fig. 1, probe II). the PCR product was confirmed by sequence analyses
of both strands. The Meq–GST fusion protein was thenThe primers 5*-TATCACTGGAGAGTCT-3* (Fig. 2B, primer
9) and 5*-TCAAAGACAGATATGGG-3* (Fig. 2B, primer 10) prepared from the soluble fraction following IPTG induction
according to the manufacturer’s instructions and purified bycorresponding to nt 265 to 281 and nt 603 to 587 of the
677-bp cDNA, respectively, were used to amplify a 338- size-exclusion chromatography using Bio-Gel A-5m matrix
(Bio-Rad, Hercules, CA). Two New Zealand rabbits werebp product from this cDNA (Fig. 1, probe I). Primer 5*-
CGGATACACAGTACCCTGTG-3* (Fig. 2B, primer 12) was injected subcutaneously with 200 mg of the purified Meq–
GST fusion protein and boosted 21, 35, 49, and 63 daysused in combination with the 3* primer 11 (5*-GTCCACACA-
TACCTTCCTGT-3*, Fig. 2B) to confirm the 5* end of the after the first immunization. Sera were collected 7 days
after the last booster and absorbed against UT-1 or CEF677-bp cDNA. PCR amplifications were carried out using
a Perkin–Elmer Thermocycler (Perkin–Elmer/Cetus, Nor- cell lysates. For immunoprecipitation experiments, 51 106
cells were either pulse-labeled for 1 hr with 100 mCi [35S]-walk, CT) and the reactions were performed essentially as
described (Shirazi and Pitha, 1992) for 30 cycles of denatur- methionine (1000 Ci/mmol, NEN) or pulse-labeled for 1 hr
and chased for 1.5 or 3.5 hr. Cell lysates were then preparedation at 957 for 1 min, annealing at 507 for 1 min, and
extension at 727 for 2 min, followed by a final extension at and subjected to immunoprecipitation, SDS–PAGE on a
12.5% gel, and autoradiography, essentially as previously727 for 10 min. For reverse transcription (RT)–PCR reac-
tions, poly(A)/ mRNA from MKT-1 or UT-1 cells was reverse described (Shirazi and Pitha, 1992).
transcribed with 200 units of M-MLV reverse transcriptase
cDNA library construction and screening(Gibco–BRL) using the downstream primer 11 and subse-
quently amplified by PCR using upstream primers 3, 5, The poly(A)/ RNA from MKT-1 cells was used to con-
or 12. struct a cDNA library using an oligo(dT) primer containing
a NcoI site (Invitrogen Corp., San Diego, CA), an EcoRIAntibody preparation and immunodetection of
adapter, and a lgt11 Sfi–Not as the cloning vector (Pro-proteins
mega), according to established protocols (Sambrook et
al., 1989). The library was then screened with 32P-labeledThe DNA sequence encoding the most antigenic protein
sequence of Meq, as predicted by computer analyses, was ClaI–SalI and SalI–BamHI subfragments of BamHI-I2 (Fig.
1, probe III and IV, respectively) and the resultant cDNAsamplified by PCR from MDV genomic DNA and cloned into
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FIG. 2. DNA sequence of cDNAs mapping to BamHI-I2 , BamHI-Q2 , and BamHI-L fragments of the MDV genome. (A and B) The sequence of the 2674-
and 667-bp cDNAs, respectively. The bold letters indicate the shared sequences between the two cDNAs. In A, the location of a sequence that is repeated
once (shown with double arrows) within the cDNA is indicated. In B, I2 and Lx/c refer to regions corresponding to portions of SalI-BamHI and XbaI–ClaI
subfragments of BamHI-I2 and BamHI-L, respectively (Fig. 1). The locations of various primer sets are shown in both A and B as arrows underlining the
respective sequence. The shaded region corresponds to a 156-bp sequence that was not homologous to MDV IRS and IRL sequences.
were subcloned directionally into SfiI–NotI sites of pGEM RESULTS
11zf(/) and sequenced. Characterization of cDNAs corresponding to the right-
hand end of the BamHI-I2 and adjacent BamHI-Q2 andNucleotide accession numbers
BamHI-L fragmentsThe sequences of the 677- and the 2674-bp cDNAs have
been deposited with the Genbank Database and assigned Screening of the cDNA library obtained from MKT-1
cells using probes corresponding to the right-hand endAccession Nos. U34966 and U34965, respectively.
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of BamHI-I2 yielded two cDNAs of sizes 2674 and 677 and 393 bp, respectively, if our assumption was correct.
As shown in Fig. 3A, two expected products of 470 andbp. Alignment of the cDNA sequences with those of MDV
IRS and IRL sequences (unpublished results) revealed 393 bp were indeed amplified from the poly(A)
/ RNA of
MKT-1 cells, but not from UT-1 cells (lanes 1–4). It isthat the 2674-bp cDNA represented a nonspliced tran-
script which spanned the right-hand end of the BamHI- also noteworthy that the primer pair 12 and 11 (Figs. 2A
and 2B) which is expected to amplify a 435-bp productI2 and the adjacent BamHI-Q2 and BamHI-L fragments
(Figs. 1 and 2A). This cDNA contained a potential poly(A) if our assumption was incorrect, failed to amplify such a
product from MKT-1 mRNA (Fig. 3A, lane 7). Furthermore,addition signal which was located at nt 2610–2615 (Fig.
2A). Computer-assisted search for the presence of poten- sequence analysis of the RT–PCR product generated
with the primer pair 3 and 10 confirmed the presence oftial ORFs within this cDNA in all reading frames, using
the TRANSLATE program of the PC/GENE software Re- such a transcript in MKT-1 cells (Fig. 3B). Thus, this cDNA
represents a spliced product of the Meq primary tran-lease 6.8 (Intelligenetics), revealed a potential bicistronic
mRNA. The first ORF (ORF-1; Figs. 1 and 2A), with the script.
start site corresponding to nt 32 and the termination site
corresponding to nt 1226 of the cDNA, encoded a 398- Detection of rightward transcripts corresponding to
aa polypeptide, which was highly homologous to the Meq BamHI-I2 , BamHI-Q2 , and BamHI-L fragments in
ORF originally described by Jones et al. (1992) and con- MDV-infected cells
tained Meq’s putative DNA binding and b-ZIP domains.
At the C-terminal region of ORF-1, a sequence corre- To study MDV gene transcription in the right-hand end
of BamHI-I2 and adjacent BamHI-Q2 and BamHI-L frag-sponding to nt 590 to 749 of the cDNA, which encoded
a stretch of prolines, was repeated once without creating ments, we performed Northern blot analysis of MKT-1
mRNA using various antisense riboprobes. As shown ina frameshift in the sequence of Meq (Fig. 2A). Using PCR
and primers 1 and 2 as well as primers 3 and 4 (see Fig. Fig. 4 (top), two main rightward transcripts of sizes 1.0
and 2.7 kb were detected in MKT-1, but not in UT-1 cells2A), we detected this repeat sequence in the genomic
DNA of the virus in MKT-1 cells (data not shown). Inter- by antisense riboprobe IV (see Fig. 1). Similar transcripts
were also detected by antisense riboprobe III, albeit atestingly, this repeat sequence was also detected in the
genomic DNA of MDV in MSB-1 cells, another lympho- a lower level (not shown). Antisense riboprobe prepared
from the 2674-bp cDNA also detected the two transcriptsblastoid cell line transformed by the BC-1 strain of MDV
(Akiyama and Kato, 1974), as well as in the attenuated, of sizes 2.7 and 1.0 kb in addition to three transcripts of
sizes 0.8, 0.3, and 0.1 kb (Fig. 4, bottom). All the tran-nononcogenic MDV strain, CVI988, but not in low-pas-
sage or high-passage RB1B strains (Schat et al., 1982) scripts detected by the 2674-bp cDNA were also de-
tected by the antisense probe prepared from the 677-bp(data not shown).
The second ORF (ORF-2) starting at nt 2072 and termi- cDNA (Fig. 4, bottom). To further delineate the origin of
these transcripts, we amplified sequences specific tonating at nt 2392 on the cDNA (Figs. 1 and 2A) encodes a
107-aa polypeptide and was identified recently in partial each cDNA by PCR, cloned the PCR products into pGEM
vector, and prepared antisense riboprobes. Probe I,cDNA clones isolated from the MDV-transformed lym-
phoblastoid cell line MDCC-CU41 with a probe spanning which encompasses the region in the 677-bp cDNA cor-
responding to the XbaI–ClaI subfragment of BamHI-Lthe BamHI-L fragment (Ohashi et al., 1994).
The 677-bp cDNA is a partial clone that represents a (see Fig. 1 for probe location), detected three rightward
transcripts of sizes 1.0, 0.3, and 0.1 kb in MKT-1 cells.spliced transcript containing sequences corresponding
to the right-hand end of the BamHI-I2 and sequences in Antisense probe II, which encompasses sequences
downstream from ORF-1 and includes the majority ofthe XbaI– ClaI subfragment of BamHI-L (Figs. 1 and 2B).
The splice donor and acceptor consensus sequences ORF-2 sequences, detected a main rightward transcript
of 2.7 kb in addition to two other transcripts of sizes 0.8were utilized for splicing of this transcript (Mount, 1982).
A potential poly(A) addition signal was found at nt 622 – and 0.3 kb (Fig. 4). Upon longer exposure, the 0.8-kb
transcript was resolved better and an additional band of628 (Fig. 2B). This cDNA contains sequences which are
homologous to part of the N-terminus of Meq (Fig. 1, 0.1 kb was detected in MKT-1 cells (not shown).
To determine whether these transcripts were re-filled boxes, and Figs. 2A and 2B, bold letters), but a 156-
bp sequence that was not homologous to the MDV IRS stricted to MKT-1 cells or could also be detected during
lytic infection by MDV, we infected CEF with CVI988and IRL sequences was found at the 5* end of this cDNA
(Fig. 2B, shaded region). Thus, we hypothesized that the strain of MDV. At 6 and 24 hr postinfection poly(A)/ RNA
was isolated and subjected to Northern blot analysis. Alatter sequence was due to a cloning artifact and this
cDNA should have contained the entire N-terminus of 2.7-kb transcript constituted the most abundant message
detected by probe IV and a less abundant transcript ofMeq. To test this hypothesis, we employed RT–PCR and
primer pair 3 and 11 as well as 5 and 11 (Figs. 2A and 1.0 kb was also detected as early as 6 hr after infection
(Fig. 4, top). Figure 4 (bottom) also shows the results of2B), which are expected to amplify two products of 470
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FIG. 3. Determination of the 5* end of the 677-bp cDNA by RT–PCR. (A) Poly(A)/ RNA from MKT-1 (lanes 1 and 3–7) or UT-1 (lanes 2 and 4)
was first reverse transcribed using a 3* primer corresponding to the XbaI–ClaI subfragment of BamHI-L (Fig. 2, primer 11) and the resultant RNA/
DNA hybrids were amplified by 5* primer 3 (lanes 3 and 4), 5* primer 5 (lanes 1 and 2), or 5* primer 12 (lane 7). Lanes 5 and 6 indicate PCR
amplification in the absence of reverse transcriptase using primer pair 5 and 11 as well as 3 and 11, respectively. The DNA Mass Ladder (Gibco–
BRL) was used as the molecular size marker. (B) Poly(A)/ RNA from MKT-1 cells was amplified by PCR using 5* (3) and 3* (10) primers (also see
Figs. 2A and 2B). The sequence of the PCR product was determined followed by cloning in the TA cloning vector, p Cr II (Invitrogen). The broken
and solid lines indicate the potential casein kinase II and protein kinase C phosphorylation consensus sequences, respectively, as predicted by
the PROSITE 12 program of the PC/GENE software Release 6.8 (Intelligenetics).
the Northern blot analyses of CVI988-infected CEF cells infection of CEF with CVI988. At 6, 24, and 48 hr after
infection, cells were pulse-labeled with [35S]methionineusing probes I and II. Probe II detected transcripts of
sizes 2.7 and 0.3 kb, and probe I detected two transcripts and cell lysates were subjected to immunoprecipitation.
Results indicated that a protein of 44 kDa appeared atof sizes 0.3 and 0.1 kb. Probe I also detected two other
transcripts of sizes 1.0 and 0.8 kb, which were detectable 24 hr after infection in CVI988-infected CEF, but not in
uninfected cells (Fig. 5B). Interestingly, an additionalupon longer exposure (not shown). Thus, virtually all the
transcripts detected in MKT-1 cells were also detected band of 28 kDa was also detected, which reached a
maximum expression at 6 hr after infection. Although thisduring lytic infection.
protein was not detected by immunoprecipitation from
Immunodetection of putative protein products MKT-1 cell lysates, it was detected by Western blot analy-
encoded by the cDNAs in lytically and latently ses of MKT-1 and MSB-1 cell lysates (not shown).
infected cells
DISCUSSIONTo detect the protein product encoded by the Meq
ORF in MKT-1 cells, we raised a polyclonal antibody We report the isolation and characterization of two
cDNA clones from a MDV-transformed and nonproduc-against part of the protein sequence of Meq, shown in
Fig. 2A as the sequence amplified by primers 5 and 6. tive tumor cell line. These cDNA clones represent tran-
scripts that map to the Meq transcriptional unit and ex-The proteins were then detected by immunoprecipitation
of cell lysates obtained from cells labeled with [35S]- tend to the BamHI-L fragment (Figs. 1 and 2). The 2674-
bp cDNA clone represents a nonspliced transcript whichmethionine for 1 hr. As shown in Fig. 5A, after the labeling
interval of 1 hr, we detected a 44-kDa band correspond- spans the right-hand end of BamHI-I2 and adjacent
BamHI-Q2 and BamHI-L fragments and contains the Meqing to the Meq ORF (ORF-1), which appeared as a doublet
in MKT-1 and in MSB-1 (not shown), but not in UT-1 cells. ORF. The sequence of Meq, however, includes a repeat
sequence (Fig. 2A) that was not present in the publishedSince Meq has the structural characteristics of a trans-
activator, we searched for its presence during the lytic sequence of the Eco-Q fragment of the GA strain (Jones
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FIG. 4. Transcriptional activity of the right-hand end of BamHI-I2 and adjacent BamHI-Q2 and BamHI-L fragments in MDV-infected cells. (Top)
Poly(A)/ RNA from MKT-1 (lane M), UT-1 (lane U), CEF (lane 1), or CEF infected with CVI988 for 6 hr (lane 2) or 24 hr (lane 3) was hybridized with
probe IV. (Bottom) Poly(A)/ mRNA from MKT-1 (lane M), UT-1 (lane U), CEF (lanes 4 and 8), or CEF infected with CVI988 for 6 hr (lane 5) or 24 hr
(lanes 6 and 7) was hybridized with probes I, II, 677-bp, and 2674-bp cDNAs. The size of each band, as indicated by the arrow, is shown on the
left. All autoradiograms represent an overnight exposure.
et al., 1992), the strain originally used to establish MKT- presence of the repeat sequence in this cDNA increases
the number of proline-rich domains, which could repress1 cells. At present, the origin and significance of such
sequence divergence is not clear. Changes in viral geno- Meq’s transactivation function (Qian et al., 1995). Future
studies, however, are required to address the functionalmic structure during serial passage of the cell-associated
virus are likely to play a role in sequence variation. Re- significance of such sequence variations.
The 2674-bp cDNA represents the 2.7-kb transcriptcently, it was demonstrated that the presence of at least
one proline repeat in the proline-rich C-terminal domain detected in either MKT-1 or cells lytically infected with
MDV (Fig. 4). cDNA cloning studies by Ohashi et al.of Meq as well as the last 33 aa was crucial for transacti-
vation activity of Meq (Qian et al., 1995). Although the (1994) resulted in two partial cDNA clones, which were
derived from mRNAs specific to BamHI-Q2 and adjacentlast 33 aa in the Meq sequence (Fig. 2A) are almost
identical to that of the published sequence of Meq, the BamHI-L fragment. By aligning these cDNAs and their
FIG. 5. Detection of Meq in MDV-infected cells. (A) MKT-1 (lanes M) and UT-1 (lanes U) cells were pulse-labeled (P) with [35S]methionine for 1
hr and chased for 1.5 or 3 hr, and cell lysates were then subjected to immunoprecipitation, SDS–PAGE, and autoradiography. (B) CEF (lane 1) or
CEF infected with the attenuated MDV strain, CVI988, for 6 hr (lane 2), 24 hr (lane 3), and 48 hr (lane 4) were pulsed for 1 hr with [35S]methionine
and cell lysates were processed as in A. Arrows point to the position of the bands. M refers to the prestained, low-range SDS–PAGE markers (Bio-
Rad).
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upstream sequences obtained by PCR amplification of sented various spliced transcripts of Meq, all of which
originated from the Eco-Q fragment. Although our North-MDV genomic DNA, the authors reported an ORF encod-
ing a 107-aa polypeptide. In addition, Ohashi et al. (1994) ern blot data did not reveal the presence of such tran-
scripts, our cDNA cloning studies indicate that gene tran-demonstrated that these cDNAs hybridized to a 2.5-kb
mRNA in MDV-transformed nonproductive cell line scription from the Meq transcriptional unit is not limited
to the Eco-Q fragment and extends to BamHI-L fragment.MDCC-CU41. Our cDNA cloning studies confirm the re-
sults by Ohashi et al. (1994) and further indicate that the Thus, the Meq transcriptional unit appears to be a com-
plex unit that contains multiple poly(A) addition signals2674-bp cDNA is a bicistronic mRNA consisting of the
Meq ORF as well as the 107-aa ORF (Fig. 1, ORF-2). The (Figs. 2A and 2B; also see Jones et al., 1992). It is possible
that differential splicing from the Meq primary transcript2.7-kb transcript appears to encode the Meq protein in
both MKT-1 and cells lytically infected with MDV (Fig. 5). could generate related, but functionally distinct, gene
products, as has been previously demonstrated for theWhether ORF-2 is also translated from this mRNA re-
mains to be determined. In view of the large intercistronic Epstein–Barr virus immediate-early BZLF1 gene (Furnari
et al., 1994). At present, however, the relationship be-space between ORF-1 and ORF-2, it is unlikely that ORF-
2 is translated from this mRNA, although in some sys- tween transcription from the right-hand end of BamHI-I2
and that from the BamHI-L fragment, if any, is not clear.tems, the efficiency of translation initiation of an internal
AUG by eukaryotic ribosomes was shown to improve BamHI-L-specific cDNAs isolated by Ohashi et al. (1994)
also hybridized to two other transcripts of sizes 0.6 andas the length of the intercistronic sequence increased
(Kozak, 1987). 0.8 kb in MDCC-CU41 cells. The authors further demon-
strated that the 0.6-kb transcript was initiated from aThe 677-bp cDNA represents a spliced transcript of
Meq containing its putative DNA binding domain (Jones TATA-containing promoter element located upstream
from ORF-2 (see Fig. 2A). Using probe II, which corre-et al., 1992; Qian et al., 1995) as well as sequences in
the BamHI-L fragment. This cDNA may represent the 1.0- sponds to ORF-2 and its upstream sequences, we de-
tected a 0.8-kb transcript as well as two other smallkb transcript which was detected either in MKT-1 or in
cells lytically infected with MDV using probes I and IV transcripts of sizes 0.3 and 0.1 kb (Fig. 4). The origin of
the former transcript remains to be determined. Sinceand the 2674- and 677-bp cDNAs (Fig. 4). Computer
search for the presence of potential ORFs indicated that this transcript was detected by all probes except probe
IV, which encompasses the majority of the Meq se-this cDNA could encode a 212-aa polypeptide in the Meq
frame of translation (also see Fig. 3B). A comparison of quence (Fig. 4), it is possible that it is initiated from the
TATA promoter element located upstream from ORF-2.the predicted aa sequence of this ORF with known pro-
tein sequences deposited in GenBank did not reveal a The small transcripts were also detected by all probes
except probe IV (Fig. 4). Assuming that these transcriptssignificant homology. However, the antibody raised
against part of the protein sequence of Meq, which could represent the same RNA species, two possibilities can
be considered to explain the presence of such smallcross react with the putative protein encoded by this ORF
(see Figs. 2A and 3B) also detected a 28-kDa protein in transcripts: (i) These small RNAs could be derived from
partially degraded intron RNAs. Since sequences ofcell lysates of cells lytically infected with MDV (Fig. 5).
This protein, however, was slightly larger than its pre- BamHI-I2 , BamHI-Q2 , and BamHI-L fragments contain
several stretches with high A content (not shown), it isdicted molecular weight, although posttranslational mod-
ification could account for its larger size. In fact, several possible that partially degraded intron RNAs containing
A-rich sequences can bind to the oligo(dT) column duringpotential phosphorylation sites were detected in the se-
quence of this ORF (Fig. 3B). It is also interesting to note the mRNA purification procedure. (ii) Such small RNAs
could represent truncated and/or highly spliced mRNAsthat examination of the aa sequence of this ORF as well
as the sequence of Meq ORF revealed striking similarity that were derived from the 0.6-kb transcript, shown by
Ohashi et al. (1994) to initiate from this region. In supportto the nuclear localization signal of SV-40 large T-antigen,
125-PPKKKRKV-132 (Kalderon et al., 1984) (Fig. 2A, nt of the latter possibility, it is important to mention that
although we were unable to detect such a transcript, our125–136). In the studies by Qian et al. (1995) the authors
indicated that the binding of Meq to the AP1-like DNA primer extension studies revealed an expected product
that corresponded to the presumed initiation site of thissequence resides in the b-ZIP domain (aa 1–129). Since
the spliced variant of Meq lacks the b-ZIP domain, future transcript (data not shown). Thus, the differences ob-
served could be due to strain variations. Nevertheless,studies are required to understand the functional signifi-
cance of this ORF, particularly with respect to DNA bind- the functional significance of these transcripts, if any,
with respect to MDV gene transcription has yet to being activity.
Previous cDNA cloning studies by Jones et al. (1992) elucidated.
Results from the present study clearly indicate thatyielded two polyadenylated cDNA clones which repre-
sented the authentic transcript encoding the Meq gene, gene transcription in the right-hand end of BamHI-I2 and
adjacent BamHI-Q2 and BamHI-L fragments is not re-as well as other cDNA clones, which presumably repre-
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coding pp38, an antigen associated with transformed cells. J. Virol.not exclude the possibility that gene products encoded
65, 6509–6515.
by transcripts from these regions function as transactiva- Curran, T., and Franza, R. (1988). Fos and jun: The AP-1 connection.
tors to modulate the gene(s) responsible for productive Cell 55, 395–398.
Finley, C. A., Hinds, P. W., and Levine, A. J. (1989). The p53 protoonco-infection and/or act as enhancers of latency-related tran-
gene can act as a suppressor of transformation. Cell 57, 1083–1093.scription.
Fukuchi, K., Sudo, M., Lee, Y. S., Tanaka, A., and Nonoyama, M. (1984).Our results also shed some light on the potential role
Structure of Marek’s disease virus DNA: Detailed restriction enzyme
of Meq in tumor induction by MDV. Previous studies had map. J. Virol. 51, 102–109.
demonstrated that the lack of expression of other MDV- Fukuchi, K., Tanaka, A., Schierman, L. W., Witter, R. L., and Nonoyama,
M. (1985). The structure of Marek’s disease virus DNA: The presencespecific genes in nononcogenic MDV strains was highly
of unique expansion in nonpathogenic viral DNA. Proc. Natl. Acad.suggestive of their role in tumor induction (Fukuchi et al.,
Sci. USA 82, 751–754.1985; Bradley et al., 1989; Peng et al., 1992). Our data
Furnari, F. B., Zacny, V., Quinlivan, E. B., Kenny, S., and Pagano,
showing the expression of Meq protein during the lytic J. S. (1994). RAZ, an Epstein-Barr virus transdominant repressor that
infection by a nononcogenic MDV strain suggest that modulates the viral reactivation mechanism. J. Virol. 68, 1827–1836.
Johnson, P. F., and McKnight, S. L. (1989). Eukaryotic transcriptionalMeq by itself is not sufficient for oncogenicity and trans-
regulatory proteins. Annu. Rev. Biochem. 58, 799–839.formation by MDV, and that it requires interaction with
Jones, D., Lee, L., Liu, J. L., Kung, H. J., and Tillotson, J. K. (1992). Marek’sother MDV and/or cellular genes. For example, Meq
disease virus encodes a basic-leucine zipper gene resembling the
could interact with gene products of the BamHI-H gene fos/jun oncogenes that is highly expressed in lymphoblastoid tumors.
family which have been shown to reduce serum-depen- Proc. Natl. Acad. Sci. USA 89, 4042–4046.
Kalderon, D., Richardson, W. D., Markham, S. F., and Smith, A. E. (1984).dent growth and prolonged proliferation of CEF in culture
Sequence requirements for nuclear location of simian virus 40 large-(Peng et al., 1993). Meq could also interact with cellular
T antigen. Nature (London) 311, 33–38.proteins such as members of the AP1 gene family (Cur-
Kozak, M. (1987). Effects of intercistronic length on the efficiency of
ran and Franza, 1988; Qian et al., 1995) or p53 tumor reinitiation by eucaryotic ribosomes. Mol. Cell. Biol. 7, 3438–3445.
suppressor protein (Finley et al., 1989) to induce tumor Landschulz, W. H., Johnson, P. F., and McKnight, S. L. (1988). The
leucine zipper: A hypothetical structure common to a new class offormation.
DNA binding proteins. Science 240, 1759–1764.
Maotani, K., Kanamori, K., Ikuta, K., Ueda, S., Kato, S., and Hirai, K.ACKNOWLEDGMENTS
(1986). Amplification of a tandem direct repeat within inverted repeats
of Marek’s disease virus DNA during serial in vitro passage. J. Virol.This work was supported by Grant RO1-CA-31949 from the National
58, 657–660.Institutes of Health and Grants 93-37204-9337 and 94-37204-0932 from
Mitchell, P. J., and Tjian, R. (1989). Transcriptional regulation in mamma-the U.S. Department of Agriculture. The authors thank Mr. Jorge Con-
lian cells by sequence-specific DNA binding proteins. Science 245,treras-Lopez for his assistance in preparation of computer graphics.
371–378.The authors also thank Ms. Kelly Field and Ms. Kim Blackford for
Mount, S. M. (1982). A catalogue of splice junction sequences. Nucleicreading and typing the manuscript.
Acids Res. 10, 459–472.
Ohashi, K., Zhou, W., O’Connell, P. H., and Schat, K. A. (1994). Character-REFERENCES ization of a Marek’s disease virus BamHI-L-specific cDNA clone ob-
tained from a Marek’s disease lymphoblastoid cell line. J. Virol. 68,Akiyama, Y., and Kato, S. (1974). Two cell lines from lymphomas of
1191–1195.Marek’s disease. Biken J. 17, 105–116.
Okazaki, W., Purchase, H. G., and Brumester, B. R. (1970). ProtectionBradley, G., Lancz, G., Tanaka, A., and Nonoyama, M. (1989). Loss of
against Marek’s disease by vaccination with a herpesvirus of turkeys.Marek’s disease virus tumorigenicity is associated with truncation
Avian Dis. 14, 413–429.of RNAs transcribed within BamHI-H. J. Virol. 63, 4129–4135.
Payne, L. N. (1982). Biology of Marek’s disease virus and the herpesvi-Buckmaster, A. E., Scott, S. D., Sanderson, M. J., Boursnell, M. E. G.,
rus of turkeys. In ‘‘The Herpesviruses’’ (B. Roizman, Ed.), p. 347. Ple-Ross, N. L. J., and Binns, M. M. (1988). Gene sequence and mapping
num, New York.data from Marek’s disease virus and herpesvirus of turkeys: Implica-
Peng, F., Bradley, G., Tanaka, A., Lancz, G., and Nonoyama, M. (1992).tions for herpesvirus classification. J. Gen. Virol. 69, 2033–2042.
Isolation and characterization of cDNAs from BamHI-H gene familyCalnek, B. W. (1980). Marek’s disease virus and lymphomas. In ‘‘Onco-
RNAs associated with the tumorigenicity of Marek’s disease virus.genic Herpesviruses’’ (F. Rapp, Ed.), p. 293. CRC Press, Boca Raton,
J. Virol. 66, 7389–7396.FL.
Peng, F., Donovan, J., Specter, S., Tanaka, A., and Nonoyama, M. (1993).Calnek, B. W. (1992). Chicken neoplasia-A model for cancer research.
Prolonged proliferation of primary chicken embryo fibroblastsBr. Poult. Sci. 33, 3–16.
transfected with cDNAs from the BamHI-H gene family of Marek’sChen, X. B., Sondermeijer, P. J. A., and Velicer, L. F. (1992). Identification
disease virus. Int. J. Oncol. 3, 587–591.of a unique Marek’s disease virus gene which encodes a 38 kilodal-
Qian, Z., Brunovskis, P., Rauscher, F., Lee, L., and Kung, H. J. (1995).ton phosphoprotein and is expressed in both lytically infected cells
The transactivation activity of Meq, a Marek’s disease herpesvirusand latently infected lymphoblastoid tumor cells. J. Virol. 66, 85–94.
bZIP protein persistently expressed in latently infected transformedChomczynski, P., and Sacchi, N. (1987). Single-step method of RNA
T-cells. J. Virol. 69, 4037–4044.isolation by acid guanidinium thiocyanate–phenol–chloroform ex-
Rispens, B. H., Van Vloten, H., Mastenbroek, N., Maas, H. J. L., andtraction. Anal. Biochem. 162, 156–159.
Schat, K. A. (1972). Control of Marek’s disease in the Netherlands.Churchill, A. E., Payne, L. N., and Chubb, R. C. (1969). Immunization
II. Field trials on vaccination with an avirulent strain (CVI988) ofagainst Marek’s disease using a live attenuated virus. Nature (Lon-
Marek’s disease. Avian Dis. 16, 126–138.don) 221, 744–747.
Cui, Z. Z., Lee, L. F., Liu, J. L., and Kung, H. J. (1991). Structural analysis Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). ‘‘Molecular Cloning:
/ m4484$7571 10-17-95 07:13:09 vira AP-Virology
599MDV TRANSCRIPTION IN INVERTED REPEATS
A Laboratory Manual,’’ 2nd ed. Cold Spring Harbor Laboratories, Cold disease virus DNA is associated with serial in vitro passage. J. Virol.
Spring Harbor, NY. 54, 690–696.
Sanger, F. S., Nicklen, S., and Coulson, A. R. (1977). DNA sequencing Silver, S., Smith, M., and Nonoyama, M. (1979a). Transcription of the
with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463– Marek’s disease virus genome in virus-induced tumors. J. Virol. 30,
5467. 84–89.
Schat, K. A., Calnek, B. W., and Fabricant, J. (1982). Characterization of Silver, S., Tanaka, A., and Nonoyama, M. (1979b). Transcription of the
two highly oncogenic strains of Marek’s disease virus. Avian Pathol. Marek’s disease virus genome in a non-productive chicken lympho-
11, 593–605.
blastoid cell line. Virology 93, 127–133.
Shirazi, Y., and Pitha, P. M. (1992). Alpha interferon inhibits early stages
Sugaya, K., Bradley, G., Nonoyama, M., and Tanaka, A. (1990). Latentof the human immunodeficiency virus type 1 replication cycle. J. Virol.
transcripts of Marek’s disease virus are clustered in the short and66, 1321–1328.
long repeat regions. J. Virol. 64, 5773–5782.Shirazi, Y., and Pitha, P. M. (1993). Interferon a-mediated inhibition of
Tanaka, A., Silver, S., and Nonoyama, M. (1978). Biochemical evidencehuman immunodeficiency virus type 1 provirus synthesis in T-cells.
of the nonintegrated status of Marek’s disease virus DNA in virus-Virology 193, 303–312.
transformed lymphoblastoid cells of chicken. Virology 88, 19–24.Silva, R. F., and Witter, R. L. (1985). Genomic expansion of Marek’s
/ m4484$7571 10-17-95 07:13:09 vira AP-Virology
